HLA-DOA, major histocompatibility complex, class II, DO alpha, 3111
N. diseases: 160; N. variants: 15
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 6 | 33007237 | non coding transcript exon variant | T/C | snv | 0.40 | 0.40 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 6 | 33006624 | 3 prime UTR variant | G/C;T | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 3 | 2007 | 2011 | ||||||||
|
1.000 | 0.120 | 6 | 33009643 | upstream gene variant | G/T | snv | 0.20 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 3 | 2007 | 2011 | |||||||
|
1.000 | 0.120 | 6 | 33010810 | upstream gene variant | C/A | snv | 0.13 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2007 | 2009 | |||||||
|
1.000 | 0.120 | 6 | 33007480 | synonymous variant | C/T | snv | 0.40 | 0.40 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.200 | 6 | 33007157 | synonymous variant | G/A;C | snv | 0.20 |
|
Digestive System Diseases; Infections | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.200 | 6 | 33007157 | synonymous variant | G/A;C | snv | 0.20 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 6 | 33007237 | non coding transcript exon variant | T/C | snv | 0.40 | 0.40 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.120 | 6 | 33006491 | 3 prime UTR variant | T/C | snv | 0.42 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 6 | 33006304 | 3 prime UTR variant | C/T | snv | 0.40 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 6 | 33007604 | non coding transcript exon variant | A/G | snv | 0.54 | 0.57 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.160 | 6 | 33010401 | upstream gene variant | T/C | snv | 0.22 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.160 | 6 | 33010401 | upstream gene variant | T/C | snv | 0.22 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.080 | 6 | 33008091 | missense variant | C/G;T | snv | 8.1E-06 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.040 | 6 | 33009477 | synonymous variant | C/A;T | snv | 4.3E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 6 | 33009477 | synonymous variant | C/A;T | snv | 4.3E-06 |
|
Neoplasms; Musculoskeletal Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 6 | 33008877 | intron variant | G/A | snv | 7.5E-02 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.120 | 6 | 33010635 | upstream gene variant | A/G | snv | 1.6E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 6 | 33006064 | 3 prime UTR variant | G/A | snv | 0.22 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.120 | 6 | 33006064 | 3 prime UTR variant | G/A | snv | 0.22 |
|
0.010 | 1.000 | 1 | 2010 | 2010 |